PAPER Gao C, Liu Y, Li L, Hölscher C

New animal models of Alzheimer's disease that display insulin desensitization in the brain.

Rev Neurosci. 2013;24(6):607-15. PubMed: 24259244

PAPER Ouchi H, Toyoshima Y, Tada M, Oyake M, Aida I, Tomita I, Satoh A, Tsujihata M, Takahashi H, Nishizawa M, Shimohata T

Pathology and sensitivity of current clinical criteria in corticobasal syndrome.

Mov Disord. 2014 Feb;29(2):238-44. Epub 2013 Nov 20 PubMed: 24259271

PAPER Henderson SJ, Andersson C, Narwal R, Janson J, Goldschmidt TJ, Appelkvist P, Bogstedt A, Steffen AC, Haupts U, Tebbe J, Freskgård PO, Jermutus L, Burrell M, Fowler SB, Webster CI

Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β.

Brain. 2014 Feb;137(Pt 2):553-64. Epub 2013 Nov 20 PubMed: 24259408

PAPER Oh H, Jagust WJ

Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid.

J Neurosci. 2013 Nov 20;33(47):18425-37. PubMed: 24259567

PAPER Steffensmeier AM, Tare M, Puli OR, Modi R, Nainaparampil J, Kango-Singh M, Singh A

Novel neuroprotective function of apical-basal polarity gene crumbs in amyloid beta 42 (aβ42) mediated neurodegeneration.

PLoS One. 2013;8(11):e78717. Epub 2013 Nov 18 PubMed: 24260128

PAPER Viet MH, Chen CY, Hu CK, Chen YR, Li MS

Discovery of dihydrochalcone as potential lead for Alzheimer's disease: in silico and in vitro study.

PLoS One. 2013;8(11):e79151. Epub 2013 Nov 18 PubMed: 24260164

PAPER Harrington MG, Chiang J, Pogoda JM, Gomez M, Thomas K, Marion SD, Miller KJ, Siddarth P, Yi X, Zhou F, Lee S, Arakaki X, Cowan RP, Tran T, Charleswell C, Ross BD, Fonteh AN

Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.

PLoS One. 2013;8(11):e79378. Epub 2013 Nov 18 PubMed: 24260210

PAPER Emily M, Talvas A, Delamarche C

MetAmyl: a METa-predictor for AMYLoid proteins.

PLoS One. 2013;8(11):e79722. Epub 2013 Nov 19 PubMed: 24260292

PAPER Lyall DM, Royle NA, Harris SE, Bastin ME, Maniega SM, Murray C, Lutz MW, Saunders AM, Roses AD, del Valdés Hernández MC, Starr JM, Porteous DJ, Wardlaw JM, Deary IJ

Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.

PLoS One. 2013;8(11):e80513. Epub 2013 Nov 15 PubMed: 24260406

PAPER Honarnejad K, Daschner A, Giese A, Zall A, Schmidt B, Szybinska A, Kuznicki J, Herms J

Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's disease.

PLoS One. 2013;8(11):e80645. Epub 2013 Nov 15 PubMed: 24260442

PAPER Hohman TJ, Koran ME, Thornton-Wells T, Alzheimer's Neuroimaging Initiative

Epistatic genetic effects among Alzheimer's candidate genes.

PLoS One. 2013;8(11):e80839. Epub 2013 Nov 18 PubMed: 24260488

Erin Bove-Fenderson

Boston University School of Medicine
Boston, United States

ApoE, ApoE Receptors & Neurodegeneration, 2014

CONFERENCE 2014-06-02 00:00:00-2014-06-03 00:00:00 University of Kentucky, Lexington, KY, U.S.A. 02 June 2014 to 03 June 2014 This yearly symposium sponsored by NIH/NIA will feature keynote speakers, talks by PPG and advisory board members, presentations from young, emerging researchers in the field, as w

The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease

CONFERENCE 2014-05-09 00:00:00-2014-05-09 00:00:00 The New York Academy of Sciences, New York, NY, U.S.A. 09 May 2014 Age is the greatest risk factor for Alzheimer's disease. Key pathways within the biology of aging may represent important targets to develop novel and effective disease-modifying drug

Experiencing Death: An Insider's Perspective

CONFERENCE 2013-12-11 00:00:00-2013-12-11 00:00:00 The New York Academy of Sciences, New York, NY, U.S.A. 11 December 2013 For millennia, human beings have wondered what happens when we die. What is the first-person experience of dying and being brought back to life? Technological advances in resuscitatio